Characterization of proteins from chronic lymphocytic leukaemic cells: Electrophoretic and immunological approach

Cytobios

Volumn 1996, Issue 340, 1996, Pages 39-49

  Chruściel, Joanna ^a   Błoński, Jerzy ^b   Krykowski, Euzebiusz ^b   Mirowski, Marek ^b   Hanausek, Małgorzata ^c   Kiliańska, Zofia M ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Chronic leukaemia; Lymphocytes; Neoplastic marker(s); Proteins

Indexed keywords

CANCER ANTIBODY; NUCLEAR PROTEIN; TUMOR ASSOCIATED PHOSPHOPROTEIN P65; TUMOR PROTEIN; TUMOR-ASSOCIATED PHOSPHOPROTEIN P65;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CELL FRACTIONATION; CHEMISTRY; FEMALE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MOLECULAR WEIGHT; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ADULT; AGED; ANTIBODIES, NEOPLASM; CELL FRACTIONATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; MOLECULAR WEIGHT; NEOPLASM PROTEINS; NUCLEAR PROTEINS;

EID: 0029690989     PISSN: 00114529     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. BLOBEL G. and Potter V. R. 1966. Nuclei from rat liver: isolation, method that combines purity with high yield. Science 154 1662-5.
2. BÖYUM A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. clin. lab. Invest. 21 77-89.
3. CONLEY C. L., Misiti J. and Laster A. J. 1980. Genetic factors predisposing to chronic lymphocytic leukemia and to autoimmune disease. Medicine 5 323-33.
4. DEL GIGLIO A., O'Brien S., Ford R., Saya H., Manning J., Keating M., Johnston D., Khetan R., El-Naggar A. and Deisseroth A. 1992. Prognostic value of proliferating cell nuclear antigen expression in chronic lymphoid leukemia. Blood 79 2717-20.
5. DE MELO N., Matutes E., Cordone I., Morilla R. and Catovsky D. 1992. Expression of Ki-67 nuclear antigen in B and T cell lymphoproliferative disorders. J. clin. Path. 45 660-3.
6. FAGUET G. B. 1994. Chronic lymphocytic leukemia: an updated review. J. clin. Oncol. 12 1974-90.
7. FAIRBANKS G., Steck T. L. and Wallach D. F. H. 1971. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 10 2606-16.
8. FOON K. A., Rai K. R. and Gale R. P. 1990. Chronic lymphocytic leukemia: new insights into biology and therapy. Ann. Intern. Med. 113 525-39.
9. GALE R P. and Foon K. A. 1985. Chronic lymphocytic leukemia. Recent advances in biology and treatment. Ann. Intern. Med. 103 101-20.
10. GALE R. P. and Foon K. A. 1987. Biology of chronic lymphocytic leukemia. Semin. Hematol. 24 209-29.
11. GALE R. P. and Foon K. A. 1988. Biology of chronic lymphocytic leukemia. In Chronic Lymphocytic Leukemia. pp 263-87. Edited by A. Polliack and D. Catovsky. Harwood Acad. Publ. GmbH Chur, Switzerland.
12. GALE R. P., Caligaris-Cappio F., Dighiero G., Keating M., Montserrat E. and Rai K. 1994. Recent progress in chronic lymphocytic leukemia. Leukemia 8 1610-4.
13. GALTON D. A. G. 1988. B-chronic lymphocytic leukemia. Some diagnostic and clinical aspects. In Chronic Lymphocytic Leukemia. pp 33-45. Edited by A. Polliack and D. Catovsky. Harwood Acad. Publ. GmbH Chur, Switzerland.
14. GAZITT Y. and Polliack A. 1988. Characterization of GP-70: a novel B-cell leukemia specific antigen and the correlation between GP-70 expression and disease activity. In Chronic Lymphocytic Leukemia. pp 67-84. Edited by A. Polliack and D. Catovsky. Harwood Acad. Publ. GmbH Chur, Switzerland.
15. GREIL R., Fasching B., Loid P. and Huber H. 1991. Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysis. Blood 78 180-91.
16. HANAUSEK-WALASZEK M., Del Rio M. and Adams A. K. 1989. Immunohistochemical demonstration of a mRNA-transport protein in rat liver putative preneoplastic foci. Cancer Lett. 48 213-21.
17. HANAUSEK-WALASZEK M., Adams A. K. and Sherman U. 1991. Expression of a 65-kDa tumor-associated protein and persistance of altered hepatic foci. Prog. clin. Biol. Res. 369 91-103.
18. INOUE T., Yamane T., Park K., Im T., Tatsumi N. and Okuda K. 1993. Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies. Arch. Path. Lab. Med. 117 969-72.
19. JULIUSSON G., Friberg K. and Gahrton G. 1988. Consistency of chromosomal aberrations in chronic B-lymphocytic leukemia. A longitudinal cytogenetic study of 41 patients. Cancer 62 500-06.
20. JULIUSSON G. and Gahrton G. 1990a. Chromosome aberrations in B-cell chronic lymphocytic leukemia. Pathogenetic and clinical implications. Cancer Genet. Cytogenet. 45 143-60.
21. JULIUSSON G., Oscier D. G., Fitchett M., Ross F. M., Stockdill G., Mackie M. J., Parker A. C., Castoldi G. L., Cuneo A., Knuutila S., Elonen E. and Gahrton G. 1990b. Prognostic subgroups in B-cell-chronic lymphocytic leukemia defined by specific chromosome abnormalities. N. Engl. J. Med. 323 720-4.
22. LAEMMLI U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 680-5.
23. LEARY J. J., Brigati J. J. and Ward D. C. 1983. Rapid and sensitive colorimetric method for visualizing biotinlabeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: Bio-blots. Proc. natn. Acad. Sci. U.S.A. 80 4045-9.
24. LOWRY O. H., Rosebrough N. J., Farr A. L. and Randall R. J. 1951. Protein measurement with the Folin phenol reagent. J. biol. Chem. 193 265-75.
25. MIKI T., Kawamata N., Arai A., Ohashi K., Nakamura Y, Kato A., Hirosawa S. and Aoki N. 1994. Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemias. Blood 83 217-22.
26. MIROWSKI M., Hanausek M., Sherman U., Adams A. K., Walaszek Z. and Slaga T. J. 1992. An enzyme-linked immunosorbent assay for p65 oncofetal protein and its potential as a new marker for cancer risk assessment in rodents and humans. Prog. clin. Biol. Res. 374 281-94.
27. MIROWSKI M., Walaszek Z. and Hanausek M. 1996 Presence of bovine fetal serum of the protein antigenically related to p65-tumor associated antigen: its isolation and polyclonal antibody production. Neoplasma 43 83-88.
28. MURAO S., Epstein A. L., Clevenger C. V. and Huberman E. 1985. Expression of maturation-specific nuclear antigens in differentiating human myeloid leukemia cells. Cancer Res. 45 791-5.
29. O'BRIEN S., del Giglio A. and Keating M. 1995. Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 85 307-18.
30. BABBITTS T. H. 1991. Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell 67 641-4.
31. RAI K. R., Sawitsky A., Cronkite E. P., Chanana A. D., Levy R. N. and Pasternak B. S. 1975. Clinical staining of chronic lymphocytic leukemia. Blood 46 219-34.
32. SABATTINI E., Gerdes J., Gherlinzoni F., Poggi S., Zucchini L, Melilli G., Grigioni F., del Vecchio M. T., Leoncini L., Falini B. and Pileri S. A. 1993. Comparison between the monoclonal antibodies Ki-67 and PC10 in 125 malignant lymphomas. J. Path. 169 397-403.
33. SAUNDERS F. K., Sharrard R. M., Winfield D. A., Lawry J., Goepel J. R., Hancock B. W. and Goyns M. H. 1993. 2D-gel analysis of proteins in chronic lymphocytic leukemia cells and normal B-lymphocytes. Leukemia Res. 17 223-30.
34. SAUNDERS F. K., Winfield D. A., Goepel J. R., Hancock B. W., Sharrard R. M. and Goyns M. H. 1994a. 2D-gel analysis of protein synthesis profiles of different stages of chronic lymphocytic leukemia. Leukem. Lymph. 14 319-22.
35. SAUNDERS F. K., Lawry J., Winfield D. A., Goepel J. R., Hancock B. W., Sharrard R. M. and Goyns M. H. 1994b. Comparison of protein synthesis profiles in chronic lymphocytic leukemia cells and B-lymphocytes from peripheral blood, cord and tonsil. Experientia 50 493-6.
36. TOWBIN H., Staechelin T. and Gordon J. 1979. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. natn. Acad. Sci. U.S.A. 76 4350-4.
37. VAHDATI M., Graafland H. and Emberger J. M. 1983. Karyotype analysis of B-lymphocyte transformed by Epstein-Barr virus in 21 patients with B cell chronic lymphocytic leukemia. Hum. Genet. 63 327-31.
38. WANG S., Mirowski M., Sherman U., Walaszek Z. and Hanausek M. 1993. Monoclonal antibodies against a 65-kDa tumor-associated phosphoprotein: development and use in cancer detection. Hybridoma 12 167-76.
39. WOŁOWIEC D., Benchaib M., Perrias P., Deviller P., Souchier C., Rimokh R., Felman P., Bayron P. A. and French M. 1995. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue. Leukemia 3 1382-8.
40. WRAY W., Boulikas T., Wray V. P. and Hancock R. 1981. Silver staining of proteins in polyacrylamide gels. Analyt. Biochem. 118 197-203.